Dermatology Advisor2h
How Does Lebrikizumab Compare to Other Monotherapies for Atopic Dermatitis?
Lebrikizumab is comparable or superior to many advanced systemic monotherapies for the short-term treatment of atopic dermatitis.
The American Journal of Managed Care20h
Atopic Dermatitis Treatment Strategies Using Ruxolitinib, Considering Crucial Role of Skin Microbiome
Lawrence F. Eichenfield, MD, FAAD, from Rady Children's Hospital and UC San Diego School of Medicine, highlighted the effectiveness of ruxolitinib cream as a nonsteroidal topical treatment for atopic ...
Dermatology Advisor2h
Tralokinumab Improves Severe Atopic Dermatitis Clinical Scores Long-Term
Tralokinumab is effective in severe atopic dermatitis for up to 18 months, with patients who are naïve to some medications having faster benefits.
Healio1h
Patients with unresponsive atopic dermatitis saw improvement with rocatinlimab
Treatment-experienced patients with moderate to severe atopic dermatitis attained higher efficacy rates on rocatinlimab ...
The American Journal of Managed Care2h
Atezolizumab, Immunogenic Chemotherapy Combination Shows Promise for DLBCL Treatment
An early pilot trial suggests that combining atezolizumab (tecectriq) with rituximab (Rituxan), gemcitabine (gemzar) and ...